| Name | Title | Contact Details |
|---|---|---|
Uma Arunagiri |
VP, Head of Patient Safety & Pharmacovigilance | Profile |
Sharon Levy |
Executive Director, Head of US People Team | Profile |
Kristen Harrington |
Chief Commercial Officer | Profile |
Kristen Harrington-Smith |
Chief Commercial Officer | Profile |
Brian Keegan |
Associate Director, Supply Chain | Profile |
Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company`s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform.
CoMentis is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology. We are applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest for safer, more effective, and cheaper drugs.
CuraPharm Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.